1887

Abstract

Following withdrawal of immunosuppression, surfactant protein A (SP-A)-deficient and wild-type mice cleared infection in a similar manner, but exhibited significant differences in lymphocyte populations, interleukin (IL)-6 levels and chemokine expression levels. A higher percentage of lymphocytes were detected in lung lavage fluid from SP-A-deficient mice, but more CD4+ T cells were isolated from lung tissue of wild-type mice. Higher concentrations of IL-6 were detected in lavage fluid and enhanced expression of lymphotactin and RANTES were detected in the lungs of wild-type mice. Equal levels of surfactant protein D were detected in SP-A-deficient and wild-type mice and no differences were detected in markers of lung injury between the two strains of mice. Thus, SP-A does not enhance organism clearance, but does modulate the host immune response during resolution of infection.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46190-0
2006-02-01
2020-09-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/2/143.html?itemId=/content/journal/jmm/10.1099/jmm.0.46190-0&mimeType=html&fmt=ahah

References

  1. Atochina E. N., Beck J. M., Preston A. M. & 8 other authors; 2004; Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 72:6002–6011 [CrossRef]
    [Google Scholar]
  2. Barry S. M., Lipman M. C., Deery A. R., Johnson M. A., Janossy G. 2002; Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 3:207–211 [CrossRef]
    [Google Scholar]
  3. Chen W., Havell E. A., Gigliotti F., Harmsen A. G. 1993; Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun 61:97–102
    [Google Scholar]
  4. Elhalwagi B. M., Zhang M., Ikegami M., Iwamoto H. S., Morris R. E., Miller M. L., Dienger K., McCormack F. X. 1999; Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol 21:380–387 [CrossRef]
    [Google Scholar]
  5. Gold J. A., Hoshino Y., Tanaka N., Rom W. N., Raju B., Condos R., Weiden M. D. 2004; Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun 72:645–650 [CrossRef]
    [Google Scholar]
  6. Korfhagen T. R., LeVine A. M., Whitsett J. A. 1998; Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta 1408296–302 [CrossRef]
    [Google Scholar]
  7. Koval C. E., Gigliotti F., Nevins D., Demeter L. M. 2002; Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 35:491–493 [CrossRef]
    [Google Scholar]
  8. LeVine A. M., Bruno M. D., Huelsman K. M., Ross G. F., Whitsett J. A., Korfhagen T. R. 1997; Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 158:4336–4340
    [Google Scholar]
  9. LeVine A. M., Kurak K. E., Bruno M. D., Stark J. M., Whitsett J. A., Korfhagen T. R. 1998; Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19:700–708 [CrossRef]
    [Google Scholar]
  10. LeVine A. M., Gwozdz J., Stark J., Bruno M., Whitsett J., Korfhagen T. 1999; Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103:1015–1021 [CrossRef]
    [Google Scholar]
  11. Limper A. H., Offord K. P., Smith T. F., Martin W. J. 1989; Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140:1204–1209 [CrossRef]
    [Google Scholar]
  12. Linke M. J., Harris C. E., Korfhagen T. R., McCormack F. X., Ashbaugh A. D., Steele P., Whitsett J. A., Walzer P. D. 2001; Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis 183:943–952 [CrossRef]
    [Google Scholar]
  13. Linke M., Ashbaugh A., Koch J., Tanaka R., Walzer P. 2005; Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection. Microbes Infect 7:748–759 [CrossRef]
    [Google Scholar]
  14. McCormack F. X., Whitsett J. A. 2002; The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109:707–712 [CrossRef]
    [Google Scholar]
  15. McCormack F. X., Gibbons R., Ward S. R., Kuzmenko A., Wu H., Deepe G. S. J. 2003; Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278:36250–36256 [CrossRef]
    [Google Scholar]
  16. McNeely T. B., Coonrod J. D. 1993; Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 167:91–97 [CrossRef]
    [Google Scholar]
  17. Morris A., Lundgren J. D., Masur H., Walzer P. D., Hanson D. L., Frederick T., Huang L., Beard C. B., Kaplan J. E. 2004; Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10:1713–1720 [CrossRef]
    [Google Scholar]
  18. Nuesch R., Bellini C., Zimmerli W. 1999; Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis 29:1519–1523 [CrossRef]
    [Google Scholar]
  19. Sepkowitz K. A. 2002; Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34:1098–1107 [CrossRef]
    [Google Scholar]
  20. Thomas C. F. J., Limper A. H. 2004; Pneumocystis pneumonia. N Engl J Med 350:2487–2498 [CrossRef]
    [Google Scholar]
  21. Thullen T. D., Ashbaugh A. D., Daly K. R., Linke M. J., Steele P. E., Walzer P. D. 2004; Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroids. Infect Immun 72:757–765 [CrossRef]
    [Google Scholar]
  22. Van Iwaarden J. F., Pikaar J. C., Storm J., Brouwer E., Verhoef J., Oosting R. S., van Golde L. M., van Strijp J. A. 1994; Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J 303:407–411
    [Google Scholar]
  23. Walzer P. D., LaBine M., Redington T. J., Cushion M. T. 1984; Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia. J Immunol 133:2502–2508
    [Google Scholar]
  24. Walzer P. D., Stanforth D., Linke M. J., Cushion M. T. 1987; Pneumocystis carinii : immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery. Exp Parasitol 63:319–328 [CrossRef]
    [Google Scholar]
  25. Wright T. W., Johnston C. J., Harmsen A. G., Finkelstein J. N. 1999; Chemokine gene expression during Pneumocystis carinii -driven pulmonary inflammation. Infect Immun 67:3452–3460
    [Google Scholar]
  26. Wu H., Kuzmenko A., Wan S., Schaffer L., Weiss A., Fisher J. H., Kim K. S., McCormack F. X. 2003; Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 111:1589–1602 [CrossRef]
    [Google Scholar]
  27. Zimmerman P. E., Voelker D. R., McCormack F. X., Paulsrud J. R., Martin W. J. 1992; 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 89:143–149 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46190-0
Loading
/content/journal/jmm/10.1099/jmm.0.46190-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error